most events occurred in patients who experienced nausea, vomiting, diarrhea, or dehydration
Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
Faler ND Video Transcription Dave: Every day were exposed to hidden chemicals that can disrupt our hormones
GGT is often the first liver enzyme to rise in non-alcoholic fatty liver disease, and a source cited in the brief notes a 2025 UK prevalence estimate of 31%, with serial monitoring helping detect early change when intervention is most effective (Mayo Clinic overview of the GGT blood test)
The added value is the medical support